SCORING MODELS FOR PREDICTING HEPATOCELLULAR CARCINOMA RISK IN HCV PATIENTS AFTER ANTIVIRAL THERAPY

SCORING MODELS FOR PREDICTING HEPATOCELLULAR CARCINOMA RISK IN HCV PATIENTS AFTER ANTIVIRAL THERAPY

Hepatitis C virus (HCV) infection is a major global health concern, with a significant risk of developing hepatocellular carcinoma (HCC) in infected individuals. The advent of oral antiviral therapy has revolutionized the management of HCV, achieving sustained virologic response (SVR) rates and redu...

Full description

Bibliographic Details
Main Authors:	Oana Irina Gavril, Cristina Iordache, Magda-Ecaterina Antohe, Codrina Ancuța, Radu Sebastian Gavril, Irina Mihaela Esanu
Format:	Article
Language:	English
Published:	Romanian Society of Oral Rehabilitation 2023-10-01
Series:	Romanian Journal of Oral Rehabilitation
Subjects:	hepatitis c virus hepatocellular carcinoma sustained virologic response
Online Access:	https://rjor.ro/scoring-models-for-predicting-hepatocellular-carcinoma-risk-in-hcv-patients-after-antiviral-therapy/

Similar Items

A NEW ERA IN HEPATIC FIBROSIS EVALUATION: NONINVASIVE INSIGHTS
by: Oana Irina Gavril, et al.
Published: (2023-12-01)

Role of LI-RADS Indeterminate Observations in the Risk of Hepatocellular Carcinoma after HCV Eradication with Direct-Acting Antivirals
by: Federica Vernuccio, et al.
Published: (2022-05-01)

Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C
by: Seong Kyun Na, et al.
Published: (2019-09-01)

Eradication of Hepatitis C Virus (HCV) Improves Survival of Hepatocellular Carcinoma Patients with Active HCV Infection – A Real-World Cohort Study
by: Luo Y, et al.
Published: (2020-07-01)

The Influence of Metabolic Factors in Patients with Chronic Viral Hepatitis C Who Received Oral Antiviral Treatment
by: Oana Irina Gavril, et al.
Published: (2023-04-01)

Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis
by: Chang Seok Bang, et al.
Published: (2017-04-01)

TEMPOROMANDIBULAR JOINT INVOLVEMENT IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS: A CROSS-SECTIONAL STUDY
by: Cristina Iordache, et al.
Published: (2018-01-01)

Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics
by: Luca Rinaldi, et al.
Published: (2020-05-01)

Effects of Achieving SVR on Clinical Characteristics and Surgical Outcomes in Patients Who Developed Early-Stage HCV-Related Hepatocellular Carcinoma and Received Curative Resection: Preoperative versus Postoperative SVR
by: Po-Yao Hsu, et al.
Published: (2022-10-01)

Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis
by: Nelson Cheinquer, et al.

Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals
by: Tatsuya Minami, et al.
Published: (2021-06-01)

Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C who achieved a sustained virological response through direct‐acting antiviral agents among the working population in Japan
by: Hideki Hagiwara, et al.
Published: (2022-06-01)

Hepatocellular carcinoma after a sustained virological response by direct‐acting antivirals harbors TP53 inactivation
by: Taisuke Imamura, et al.
Published: (2022-04-01)

Evaluation of carbohydrate and lipid metabolism dynamics in chronic HCV diabetic patients treated with direct antiviral agents
by: Irina Duport-Dodot, et al.
Published: (2023-06-01)

Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis
by: Georges-Philippe Pageaux, et al.
Published: (2022-01-01)

Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis
by: Chiara Rocha, et al.
Published: (2023-05-01)

Simple score to predict risk of hepatocellular carcinoma in chronic hepatitis C patients with advanced fibrosis after pegylated interferon and ribavirin therapy
by: Hu CC, et al.
Published: (2018-04-01)

Body mass index (BMI) and alpha-fetoprotein (AFP) level correlate with the severity of HCV-induced fibrosis in a cohort of Egyptian patients with chronic HCV
by: Amal Ahmed Mohamed, et al.
Published: (2020-10-01)

Characteristics of hepatocellular carcinoma in patients with hepatitis C virus who received direct‐acting antiviral therapy and achieved sustained virological response: The impact of a hepatologist on surveillance
by: Toshifumi Tada, et al.
Published: (2022-07-01)

General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after direct‐acting antiviral therapy
by: Toshifumi Tada, et al.
Published: (2022-07-01)

Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR
by: Ming-Lun Yeh, et al.
Published: (2021-07-01)

A validation study of after direct‐acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infection who had received direct‐acting antiviral therapy and achieved sustained virological response
by: Toshifumi Tada, et al.
Published: (2022-01-01)

The care cascade for hepatitis C virus and prognosis of chronic hepatitis C patients treated with antiviral agents in a tertiary hospital
by: Sung Hwan Yoo, et al.
Published: (2023-04-01)

The Impact of Cirrhosis and History of Hepatocellular Carcinoma on All-Cause Mortality After Eradication of Hepatitis C Virus in Patients With Chronic Hepatitis C
by: Hidenori Toyoda, et al.
Published: (2022-01-01)

Antiviral therapy and risk for hepatocellular carcinoma in chronic viral hepatitis
by: D T Abdurakhmanov
Published: (2013-10-01)

Stratification of Hepatocellular Carcinoma Risk Following HCV Eradication or HBV Control
by: Pierre Nahon, et al.
Published: (2021-01-01)

Experience of effective antiviral therapy in a liver recipient with recurrent HCV infection genotype 1
by: D. V. Umrik, et al.
Published: (2019-01-01)

Effect of Successful Direct Acting Antivirals Therapy on Liver Stiffness in Patients with Chronic HCV Infection
by: Ibrahim Anam Ezzelregal, et al.
Published: (2020-10-01)

Attach importance to antiviral therapy in patients with hepatocellular carcinoma caused by hepatitis virus
by: Shuling Wu, et al.
Published: (2023-01-01)

Treatment Adherence to Nucleos(t)ide Analogs in Chinese Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma: A Single-Center Cross-Sectional Study
by: Li Y, et al.
Published: (2021-08-01)

Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens
by: Olga Tronina, et al.
Published: (2023-03-01)

Direct-Acting Antiviral Agents for HCV-Associated Glomerular Disease and the Current Evidence
by: Fabrizio Fabrizi, et al.
Published: (2019-10-01)

Correlation between low-level viremia and hepatitis B-related hepatocellular carcinoma and recurrence: a retrospective study
by: Furong Sun, et al.
Published: (2021-10-01)

Hepatocellular Carcinoma Prevention in the Era of Hepatitis C Elimination
by: Jeffrey V. Lazarus, et al.
Published: (2023-09-01)

Viral elimination is essential for improving surgical outcomes of hepatitis C virus‐related hepatocellular carcinoma: Multicenter retrospective analysis
by: Masao Nakajima, et al.
Published: (2020-11-01)

Correlations between PNPLA3 Gene Polymorphisms and NAFLD in Type 2 Diabetic Patients
by: Oana Irina Gavril, et al.
Published: (2021-11-01)

Case report: 8 years after liver transplantation: de novo hepatocellular carcinoma 8 months after HCV clearance through IFN-free antiviral therapy
by: Giuliano Ramadori, et al.
Published: (2018-03-01)

Long-Term Follow-Up of Advanced Liver Disease after Sustained Virological Response to Treatment of Hepatitis C with Direct-Acting Antivirals: Outcomes from a Real-World Portuguese Cohort
by: Tiago Pereira Guedes, et al.
Published: (2019-10-01)

Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment
by: Dash S, et al.
Published: (2020-04-01)

Low Incidence of Hepatocellular Carcinoma after Antiviral Therapy in Patients with Chronic Hepatitis C and Hemophilia
by: In Jung Kim, et al.
Published: (2022-03-01)